Breaking News
Get 40% Off 0
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list
Close

Loncar Cancer Immunotherapy ETF (CNCR)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
14.36 -0.21    -1.44%
18/04 - Closed. Currency in USD ( Disclaimer )
After Hours
14.36
0.00
0.00%
16:15:00 - Real-time Data
Type:  ETF
Market:  United States
Asset Class:  Equity
  • Volume: 1,755
  • Bid/Ask: 13.69 / 17.20
  • Day's Range: 14.36 - 14.63
Loncar Cancer Immunotherapy 14.36 -0.21 -1.44%

CNCR Recent Sentiments

 
Information on users’ sentiments for the Loncar Cancer Immunotherapy ETF, which are displayed both on charts of different periods of time and on a detailed table.
Start Date Username Call Open Rate End Date Chg. %
Feb 27, 2024 MarionMaréchal   16.70 Mar 04, 2024 @ 17.33 +3.77%
Feb 21, 2024 Mike Jackowski   15.77 Mar 15, 2024 @ 16.26 +3.11%
Aug 22, 2022 David Lawton   16.39 Sep 16, 2022 @ 15.46 +5.67%
Jun 06, 2022 sayedhossein sadr   14.42 Jul 01, 2022 @ 15.50 +7.48%
May 10, 2022 Ulises Villalta   14.24 Jun 03, 2022 @ 14.28 +0.28%
Jan 06, 2022 Lorenzo Bertolotti   22.05 Jan 28, 2022 @ 18.36 -16.74%
Jun 18, 2021 Daniel Gonzalez   30.64 Jul 09, 2021 @ 31.37 +2.38%
Nov 10, 2020 Russom   28.00 Dec 04, 2020 @ 32.29 -15.32%
May 18, 2020 Perma   27.37 Jun 12, 2020 @ 25.27 -7.66%
May 07, 2020 galena   23.50 May 29, 2020 @ 26.49 +12.74%
Dec 27, 2019 kugler47   24.11 Jan 17, 2020 @ 23.45 -2.72%
Nov 05, 2019 Francois Maz   20.34 Nov 29, 2019 @ 23.46 +15.34%
Sep 19, 2019 Dan Elbon   20.05 Oct 11, 2019 @ 18.35 -8.48%
Apr 02, 2019 Clement Coenen   21.41 Apr 26, 2019 @ 20.55 +4.00%
Mar 13, 2019 LUIS MARTIN GARCIA   21.24 Apr 05, 2019 @ 22.36 +5.27%
Feb 13, 2019 Eric Sorensen   21.80 Mar 15, 2019 @ 21.34 +2.11%
Dec 19, 2018 Ross Keiser   18.36 Jan 18, 2019 @ 21.49 +17.05%
Oct 22, 2018 Francois Maz   20.55 Nov 21, 2018 @ 21.49 +4.57%
Sep 14, 2018 Eric Sorensen   24.40 Oct 14, 2018 @ 21.49 -11.93%
Apr 04, 2018 ДМ ДМ   28.01 May 04, 2018 @ 26.40 -5.75%
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

CNCR Comments

Write your thoughts about Loncar Cancer Immunotherapy ETF
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email